QoL Extended With Atezolizumab + Bevacizumab in Liver Cancer

And, triplet and doublet drug regimens delay decline in quality of life in BRAF V600E metastatic CRC
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pharmacy, Conference News, Source Type: news